Medical Device and Wound Care News and Analysis Blog

SmartTAKE: Ortho News and Analyst Insights from SmartTRAK

Written by Sharon O'Reilly | 10/20/26, 1:30 PM

Keeping up with the latest developments in orthopedic technologies takes more than just following the headlines. Every day, SmartTRAK's orthopedic analysts go beyond the news to provide expert analysis and perspective in real-time through their SmartTAKE Daily Updates.

Knowing what's happening in MedTech is important, but the real value comes from understanding why it's happening and what it means. Subscribe to SmartTRAK for daily SmartTAKEs from our expert analysts, providing the insights and market intelligence that help you make smarter, more informed decisions.

Below is a small sampling of their insights covering Orthobiologics, Regenerative Medicine, Spine, Bone Replacement, Soft Tissue Fixation, Arthroscopic Technologies, Total Joint Arthroplasty and Enabling Technologies.

Early Exercise Dictates Cartilage Adaptation
Research shows that mechanical loading from early training drives functional adaptation in equine cartilage. SmartTRAK believes this has implications for earlier rehabilitation, as mechanical load drives cartilage's biochemical composition and structure. David Shepard, GM, Orthobiologics & Regenerative Medicine

Removing Pins, Towers and CT Could Accelerate Robotic TKA Adoption in ASCs
SmartTRAK
expects that technologies that remove pins, camera towers and mandatory CT scans will lower OR setup time and capital footprint and thereby eliminate the two biggest barriers to running robotic TKA in an ASC. Erin Dorgan, Sr Analyst, Spine & Bone Replacement

Stable Procedure Volumes Drive Arthroscopic Technologies Consumables in Q226
Steady procedure volumes supported recurring demand for AT consumables across mechanical resection, radiofrequency ablation and fluid management in Q226. Andy Knapik, Sr Analyst, Soft Tissue & Arthroscopic Technologies

SmartTRAK Sees Extremities Reducing Kuros’ Reliance on Medtronic
As Kuros expands in extremities, SmartTRAK expects Medtronic-related spine revenue to represent a smaller share of total sales, signaling broader diversification beyond its current spine distribution relationship. Erin Dorgan, Sr Analyst, Spine & Bone Replacement

SNN’s LANDMARK To Reverse SNN Knee Trajectory
Smith+Nephew announced it has received FDA 510(k) clearance for its cementless LANDMARK Total Knee System, an anatomy‑driven implant built to restore natural motion and fully leverage CORI Handheld Robotics for personalized alignment across hospital and ASC settings. SmartTRAK expects LANDMARK to materially strengthen SNN’s knee competitiveness, closing the long‑standing cementless portfolio gap that has dragged its US Knee growth. W/ an on‑time Q3 launch, LANDMARK is positioned to help reverse SNN’s lagging US knee trajectory. Tracy Martellotta, Sr Analyst Joint Arthroplasty

Q226 US Joint Fluid Replacement Market Recap
Talks of Sanofi’s potential sale of its Synvisc-One/Synvisc franchise have been active since 2025. SmartTRAK believes that Sanofi’s move to relist the franchise in earnings reports and a renewed surge in revenue for Q226 could raise interest w/ potential parties if any exist. Freddy Buntoum, Sr Analyst Orthobiologics & Regenerative Medicine

Smith+Nephew
SmartTRAK believes TESSA represents an important step forward for arthroscopy, a mkt that has seen relatively few major technology advances in recent years and could help usher in a new era of digital navigation and procedure-specific guidance in the sports medicine space. Andy Knapik, Sr Analyst, Soft Tissue & Arthroscopic Technologies

Keys to Success in the Coming Quarters for the Spine Market
SmartTRAK
believes that success in the upcoming quarters will come not just from raw implant volume, but also from a company’s ability to build localized, intelligent and personalized surgical ecosystems that fulfill both clinical and economic mandates. Erin Dorgan, Sr Analyst, Spine & Bone Replacement

8i Multi-Arm Spine Robot
SmartTRAK
learned at NASS 2026 that 8i Robotics plans to submit for FDA 510(k) clearance next year for its multi-arm spine robot. Although the 8i robot is an open platform system, the company has a strategic alliance w/ Implanet to be compatible w/ their implants. Elise Wolf, VP & GM, Orthopedics, Digital & Quality

Get the insights behind the headlines. Subscribe to SmartTRAK for daily SmartTAKEs packed with expert analysis, competitive intelligence and the market insights you need to stay one step ahead of the competition. Click the button below to learn more.


SmartTRAK is the Medtech industry’s only global Insights-as-a-Service solution for the Orthopedics, Wound Care, Regenerative Medicine and Neuro Therapy markets. SmartTRAK’s proprietary methodology turns disparate data from hundreds of sources into powerful insights customers can rely on as the trusted source for strategic decision-making. The SmartTRAK enterprise platform includes rich daily updates, comprehensive market coverage and simple-to-use tools and dashboards for market, product and financial analysis. Customers leveraging the SmartTRAK platform also have direct access to market experts for inquiries and advisory services. If you would like a demo of what SmartTRAK offers and how we can help increase proficiency, improve productivity and reduce costs for your company, just click here.